Health-related content. Aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before making decisions. .

Ozempic® Suomi

Ozempic® Suomi

By NovoNordisk A/S

Ozempic® Suomi is a medical support application developed by NovoNordisk A/S designed to assist adults prescribed Ozempic® for type 2 diabetes. The app provides digital tools for treatment tracking, educational resources, and medication administration guidance.

Overview · Full Intel report in progress

The App DNA

What makes this app unique?

For Adults diagnosed with type 2 diabetes who have been prescribed Ozempic®.

What does it look like?

Key features

Treatment Schedulingstandard

Allows users to set weekly reminders and find appropriate times to take their medication.

Appointment Managementstandard

Provides functionality to schedule visits with healthcare professionals.

Treatment Monitoringstandard

Enables users to view, download, and share information regarding their treatment progress.

Instructional Contentstandard

Includes educational videos demonstrating the correct usage of the Ozempic® device.

How much does it cost?

free

Velocity

See all version history

Who built it?

NovoNordisk A/S

3 apps tracked · Medical

すくすく成長曲線すくすく成長曲線Ozempic AUOzempic AU
Explore the full publisher profile

User Sentiment

What do users think recently?

How are ratings & reviews evolving?

Google Play
3.60 · 15

Not enough recent reviews to extract reliable themes yet.

Read the full review analysis

Competition

Competitive landscape for Ozempic® Suomi

How's the Medical market?

The rivals identified

The Analyst's Read

Key takeaways for Ozempic® Suomi

Where is it heading?

Bottom line

The app serves as a companion tool for patients to manage their Ozempic® treatment regimen through reminders, tracking, and instructional resources.

Report last updated

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with automated quality gates, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by Ozempic® Suomi, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

Cite this report

Marlvel.ai. “Ozempic® Suomi Intelligence Report.” Updated May 19, 2026. https://marlvel.ai/apps/com-novonordisk-semafinland

Agent Markdown (.md)See methodologyContact support

Data licensed under CC-BY-NC 4.0